All pairs

Atazanavir and Glecaprevir–pibrentasvir

Desk tier: Avoid together

Mechanism: weak CYP3A4 inhibition of clearance (↑ exposure)

“Coadministration is contraindicated with, but not limited to, the following drugs”
Reyataz (atazanavir), section 4 CONTRAINDICATIONS (Table 6). DailyMed label

Open this pair in the desk

All pairs for Atazanavir · Glecaprevir–pibrentasvir

Enzyme behind this pair: CYP3A4

Educational reference only. Not FDA-cleared. The Prescribing Information governs.